This inventor holds 2 USPTO granted patents. Top assignees: Laboratoire Glaxo Wellcome, Laboratoires Glaxo S.a.. Active years: 1995-2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1995-2000
Title: Alain Emile Schaeffer: Innovator in Pharmaceutical Compositions
Introduction
Alain Emile Schaeffer is a notable inventor based in Evreux, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for medical use. With a total of 2 patents to his name, Schaeffer's work has had a meaningful impact on the treatment of various health conditions.
Latest Patents
Schaeffer's latest patents include an inhalation device and effervescent pharmaceutical compositions. The effervescent compositions are designed for oral use and consist of a base component and an acid component that react in the presence of water to generate gas. These compositions also include a compound that acts as a 5HT1-like receptor agonist or a physiologically acceptable salt or solvate thereof as the active ingredient. Additionally, methods for manufacturing these compositions and their application in treating cephalic pain are described in his patents.
Career Highlights
Throughout his career, Alain Emile Schaeffer has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Laboratoires Glaxo S.A. and Laboratoire Glaxo Wellcome. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.
Collaborations
Schaeffer has collaborated with various professionals in his field, including his coworker Etienne Seguelas. Their joint efforts have likely enhanced the quality and effectiveness of the inventions they have worked on together.
Conclusion
Alain Emile Schaeffer is a distinguished inventor whose work in pharmaceutical compositions has paved the way for advancements in medical treatments. His innovative approach and collaboration with industry leaders continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile